(A) Immunoblots for the detection of recombinant GST-HuR and GST-HA-HuR proteins in total bacterial extracts (TE) and eluted purified fractions (EL) using anti HA and anti HuR antibodies. Ponceau S (PonS) staining is shown as a protein loading control.
(B) R-EMSA using specific 32 P-labeled riboprobe (SP) containing the TNF 3'HBM/ARE incubated with the indicated concentrations of GST-HuR, GSTHAHuR, or GST; note the gradual appearance of a low and a high mobility complex (c1-c2). The specificity of protein binding was assessed in competition assays by adding an excess amount of cold probe (comp).
(C) Protein titration curves for complex C1 (• HuR and ○ HA-HuR) and complex C2 (▼HuR and HA-HuR) indicating the similarities in binding. Values are relative numbers of a phosphorimager reading of the bound RNA from different protein concentrations used in (B).
(D) R-EMSA with the recombinant proteins GST-HuR and GST-HAHuR using increasing amounts of both specific (SP) and mutant (MP) 32 P-labeled riboprobes to assess specificity and relative affinities. (F) Assessing the specificity of binding in transgenic macrophage extracts. R-EMSA with cytoplasmic extracts from Tg632 (Tg) and wild-type (NT) macrophages; protein extracts were incubated with the specific probe containing the 3'HBM/ARE of TNF mRNA (SP) yielding three complexes (c1, c2, c3). The specificity of the protein binding is shown by using the mutant (MP) 32 P-labeled riboprobe or in competition assays with cold riboprobes (SP cold , MP cold ).
(G) Primary sequence for the transcribed human TNF HBM/ARE (GeneBank# NM000549) containing riboprobes used in this study. The specific probe (SP) contains the natural sequence whereas in the mutant probe (MP) every UU or UUU has been replaced by UG and GGU respectively.
Supplemental Experimental Procedures: Figure S1

Generation of Recombinant GST-HA-HuR Protein
For the production of recombinant GST-HA-HuR protein, pGEX-HuR vector was used, as described by Ma et al. (1996) by replacing HuR with the HA-HuR cDNA that was used for the transgene generation. Constructs were expressed in BL-21 bacterial strain and were purified, 3 hr after IPTG induction to a final concentration of 1 mM, using the MagneGST Protein Purification System (Promega) according to manufacturer's instructions.
RNA:Protein Interactions
The mobility shift assays were performed as described in the main text Experimental Procedures. 
Supplemental Experimental Procedures: Figure S2
The murine myelomonocytic cell line RAW264.7 was acquired from ATCC (USA) and maintained in RPMI1640+5%FBS medium. Prior to experimentation, cells were seeded at a density 1-5 × 10 7 cells/10cm 2 tissue culture plate. mRNP isolation and RIP assays were performed as described in the main text. N Mm. 307887 na R Cytokine and chemokine transcripts examined in 10 µg of total RNA isolated from LPS stimulated transgenic macrophage cultures using Ribonuclease Protection Assays (R) and Northern Blots (N). Indicated are the messages detected (italics), their corresponding Unigene annotation numbers, the cluster of AU-rich elements that they contain according to the ARED database and the type of variation that was observed following the induction of transgenic HuR. White-not detected; Gray-no variation; Green-downregulated; Red-upregulated. *IFNγ mRNA was detected in traceable amounts. Methods: 5 µg of cellular RNA were used for Ribonuclease protection analysis using the Riboquant probes (Pharmigen) mCK1b, mCK-3b, mCK-5c and the RPAIII kit (Ambion) according to manufacturer's instructions. Protected 32 Plabeled fragments were analyzed in 5% acrylamide-urea gels and visualized using a STORM Phosphorimager device. Northern blots were performed as described in the main text. 
